Search our Innovation Portfolio

CGM devices have undoubtedly improved diabetes treatment but have significant problems, particularly for children, as they can cause skin damage and reactions, altering the correct results.

The innovation uses hair follicles to extract fluid from under the skin without damage. This fluid closely reflects blood glucose levels, so patients and parents can use it to plan treatment on a minute-by-minute basis. The device is a wearable with a disposable skin patch. It is a user-friendly and discreet solution. A mobile app communicates results from the patch on the skin to the user's smartphone to provide immediate readings for action.

Augmented Reality app for children and young people in the first year following diagnosis with epilepsy tailored to each individual to enhance patient and carer understanding of epilepsy, provide safety advice for greater confidence in managing epilepsy at home and enable greater communication with clinicians to improve patient outcomes. This will make use of augmented reality to show patients how their epilepsy occurs and how their treatment works. The information will also be tailored to each user's learning level and made available on a wide range of mobile devices so that as many people as possible can use the app.

The prototype innovation allows at-home or primary care testing of micronutrient levels using an integrated finger-prick and minimal amount of blood. The innovation pairs microfluidics and lateral flow technology to enable parallel semi-quantitative testing of numerous analyte concentrations. The device is simple to use eliminating additional apparatus and complex steps. Results will be analysed using a phone app for clear decision-making, with data uploaded to healthcare providers automatically.